Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections
- 1 December 1989
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (12) , 1102-1110
- https://doi.org/10.1007/bf01975177
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Mechanisms of Aminoglycoside Resistance in Variants of Pseudomonas aeruginosa Isolated During Treatment of Experimental Endocarditis in RabbitsThe Journal of Infectious Diseases, 1988
- Long-term oral ciprofloxacin: Experience in the treatment of incurable infective endocarditisThe American Journal of Medicine, 1988
- ORAL CIPROFLOXACIN COMPARED WITH CONVENTIONAL INTRAVENOUS TREATMENT FOR PSEUDOMONAS AERUGINOSA INFECTION IN ADULTS WITH CYSTIC FIBROSISThe Lancet, 1987
- Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1986
- Efficacy of Ciprofloxacin in Experimental Arthritis Caused by Escherichia coli -- in Vitro-in Vivo CorrelationsThe Journal of Infectious Diseases, 1985
- Uptake of ciprofloxacin by human neutrophilsJournal of Antimicrobial Chemotherapy, 1985
- The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitroEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In-vitro activity of enoxacin (CI-919), a new quinoline derivative, compared with that of other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1984
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- ACUTE ARTHRITIS CAUSED BY GRAM-NEGATIVE BACILLIMedicine, 1974